Reveal LINQ vs Sleepiz One+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Medtronic
VS
by Sleepiz

AI Verdict

These tools are adjacent in their remote patient monitoring capabilities but serve distinct primary functions. Reveal LINQ is an implantable device focused on long-term, continuous ECG monitoring and AI-powered arrhythmia detection for cardiac conditions. Sleepiz One+ is a contactless bedside device that monitors respiration and heart rate, primarily for sleep apnea screening and general remote patient monitoring in senior care.

Choose Reveal LINQ if…

Choose Reveal LINQ if you require long-term, continuous, and highly accurate ECG monitoring for up to three years to diagnose elusive cardiac arrhythmias like atrial fibrillation, cryptogenic stroke, or unexplained syncope. This implantable device is ideal for patients experiencing infrequent symptoms that are difficult to capture with shorter-term monitoring methods, offering AI-powered analysis to reduce false alerts and MRI compatibility for patient convenience.

View Reveal LINQ →

Choose Sleepiz One+ if…

Choose Sleepiz One+ if you need contactless, remote patient monitoring of respiration rate and heart rate, particularly for managing chronic conditions or for use in senior care settings. This bedside device is suitable for patients who prefer non-wearable solutions and allows for continuous data collection during sleep, providing insights into physiological status and aiding in the early detection of clinical deterioration.

View Sleepiz One+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Reveal LINQ Sleepiz One+
Pricing Contact vendor for pricing Contact for pricing
Deployment Implantable medical device with a bedside patient monitor (MyCareLink™) for data transmission and a mobile app (Reveal LINQ™ Mobile Manager) for clinicians. Wall-mounted or bedside table placement, Wi-Fi connectivity
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Sleepiz One+

Sleepiz One+ offers superior usability due to its completely contactless nature and easy setup, requiring no wearables or an invasive procedure. Users simply place the device on a bedside table or mount it on a wall. In contrast, Reveal LINQ is an implantable device, which, while minimally invasive, still requires a surgical procedure and a bedside monitor for data transmission.

Clinical Value

Reveal LINQ

Reveal LINQ demonstrates higher clinical value by providing continuous, long-term ECG monitoring for up to three years, utilizing AI algorithms for accurate detection of various cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. Sleepiz One+ focuses on remote monitoring of respiration and heart rate, and sleep apnea screening, which, while valuable, addresses a narrower range of critical conditions compared to the comprehensive cardiac arrhythmia detection of Reveal LINQ.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing, indicating a lack of public transparency. While Sleepiz One+ mentions CPT codes for reimbursement, and Medtronic's Reveal LINQ pricing is often integrated into procedure costs and covered by insurance, neither provides concrete pricing details for a direct comparison of value.

Enterprise Readiness

Reveal LINQ

Medtronic, as a large and established medical device company, likely offers more robust enterprise-level support, integration capabilities, and established workflows for healthcare systems. Reveal LINQ's deployment as an implantable device with a dedicated network (CareLinku2122) and clinician app suggests a more integrated and mature enterprise solution. Sleepiz One+ is a newer company, and while its contactless monitoring offers ease of deployment, its enterprise readiness may not be as extensive as Medtronic's.

Innovation

Tie

Both tools showcase significant innovation in their respective fields. Reveal LINQ's miniaturized, implantable design with AI-powered arrhythmia detection and long-term monitoring is highly innovative for cardiology. Sleepiz One+'s contactless radar technology for remote patient monitoring, particularly for sleep apnea screening and vital signs, represents a novel and user-friendly approach to at-home healthcare.

Support & Docs

Reveal LINQ

Medtronic, with its long-standing presence in the medical device industry, provides extensive support and documentation for Reveal LINQ, including patient and clinician manuals, technical services, and patient services. Sleepiz offers quick start guides and instruction manuals, and FAQs, but Medtronic's established infrastructure likely provides a more comprehensive and readily available support system.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Reveal LINQ Sleepiz One+
Device Type Implantable cardiac monitor Contactless remote patient monitoring device
Monitoring Duration Up to three years Not specified
Key Biometrics Monitored ECG (for cardiac arrhythmias, atrial fibrillation, cryptogenic stroke, unexplained syncope) Respiration rate, heart rate, sleep apnea screening
AI Algorithms AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause) AI-powered data analysis
Specialties Cardiology, Neurology Geriatrics, Pulmonology, Sleep Medicine
Unique Feature World's smallest insertable cardiac monitor (1.2 mL), MRI Conditional (1.5T and 3T) with no post-insertion waiting Contactless monitoring (radar technology)

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ and Sleepiz One+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Reveal LINQ involves a minimally invasive implantation procedure, after which the device continuously records ECG data. Patients use a bedside monitor (MyCareLinku2122) for data transmission, and clinicians can manage the device via a mobile app (Reveal LINQu2122 Mobile Manager). Sleepiz One+ is a contactless bedside device that is easy to set up, typically within 3 minutes, and requires no wearables, making the patient experience straightforward. Physicians access data through a web application, which can also send automated SMS/email notifications for events like bed exits or abnormal vital signs.
The provided information does not explicitly detail the depth of EHR integration for either Reveal LINQ or Sleepiz One+. For Reveal LINQ, data is transmitted to the CareLinku2122 network. Sleepiz One+ data is accessible via a web application or API, which could facilitate integration into clinical trial workflows and potentially other platforms. For multi-site rollouts, Sleepiz One+ emphasizes easy setup and deployment with Wi-Fi connectivity, and a multi-resident dashboard for data access, suggesting suitability for broader implementation.
Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to detect cardiac arrhythmias, with Medtronic reporting a 99.7% AF detection accuracy rate. However, some studies have indicated high false positive rates for AF (ranging from 46% to 86%) and pauses (close to 80%) in Reveal LINQ, though AI-based solutions have shown promise in reducing these. Sleepiz One+ has demonstrated high accuracy in measuring breathing rate (99%) and heart rate (96%) compared to gold-standard methods. Its AI-powered data analysis aims to provide reliable insights for chronic conditions and sleep apnea screening.
Medtronic emphasizes the protection of patient health data for Reveal LINQ, acknowledging HIPAA obligations. Sleepiz One+ is ISO 27001 and ISO 27701 certified, in addition to being HIPAA compliant. Sleepiz One+ implements administrative, physical, and technical safeguards including encryption in transit and at rest, multi-factor authentication, role-based access control, intrusion detection, security monitoring, regular penetration testing, and data pseudonymization. It also retains audit logs as required by law or organizational directives.
Medtronic provides patient service specialists for Reveal LINQ, with customer support available Monday through Friday, 7:00 a.m. to 7:00 p.m. CT. Technical services are also available. Sleepiz offers customer support via email and phone, available Monday to Friday from 09:00 to 17:00.
Reveal LINQ offers continuous monitoring for up to three years, providing long-term data for diagnosing infrequent arrhythmias and assessing treatment effectiveness, with clinical evidence supporting its use in cryptogenic stroke, syncope, and atrial fibrillation. Sleepiz One+ is designed for quick setup (under 3 minutes) and continuous, contactless monitoring, aiming to provide immediate insights into vital signs and sleep patterns. Sleepiz highlights its use by physicians in routine diagnostics and follow-up, and in long-term studies, suggesting established clinical utility. While direct customer references aren't explicitly stated as available, both companies mention clinical studies and physician use.

Backers

Who funded each tool's parent company.

Sleepiz One+

AI Tool Finder
AI-powered search. Results may not be comprehensive.